# Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

> **NCT00847626** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 1711 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Azilsartan medoxomil and chlorthalidone
- **DRUG:** Chlorthalidone
- **DRUG:** Chlorthalidone
- **DRUG:** Azilsartan medoxomil
- **DRUG:** Azilsartan medoxomil
- **DRUG:** Azilsartan medoxomil

## Key facts

- **NCT ID:** NCT00847626
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-07
- **Target enrollment:** 1711 (ACTUAL)
- **Last updated:** 2012-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847626, "Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00847626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*